Survival of patients with early invasive melanoma down-staged under the new eighth edition of the American Joint Committee on Cancer staging system - 13/12/18
Funding sources: Supported by National Health and Medical Research Council (NHMRC) program grants 1073898 and 552429. Dr von Schuckmann is funded by NHMRC postgraduate scholarship 1133317. Dr Khosrotehrani was funded by a NHMRC Career Development Fellowship. |
|
Disclosure: Prof Lorigan has used a grant provided by Bristol-Myers Squibb and received honoraria from Pierre Fabre, Nera Care, Amgen, MSD, Novartis, and Bristol-Myers Squibb for participating in research projects outside this work. Dr von Schuckmann, Ms Hughes, Dr Lee, Prof Lorigan, A/Prof Kiarash Khosrotehrani, Prof Smithers, and Prof Green have no conflicts of interest to disclose. |
|
The funding body played no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication. |
|
Reprints not available from the authors. |
Vol 80 - N° 1
P. 272-274 - janvier 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?